Dr. John H. Rundback discusses a report from the Pathfinder registry that takes a look at using the Auryon laser for PAD, the utilization of tacks in tibial interventions, and TOBA II BTK 12-month results.

Dr. Robert E. Beasley discuss treatment options for tibioperoneal disease. He highlights how there is only one FDA-approved treatment option available for below-the-knee tibial vessels—balloon angioplasty. He reviews other options such as…

Currently about one third of all endovascular procedures and 25% of all lower extremity arterial revascularization procedures are performed in an office-based setting. These numbers are expected to increase by a record setting 5% per year, over the…

Presenting an update on the COMPARE trial, Marianne Brodmann, MD, from Medical University Graz in Graz, Austria split her presentation into 2 parts: the first, 1-year data from the RANGER II SFA long lesion cohort, and the second, a 2-year update of…

Dr. Fadi Saab discusses which scenarios are ideal for use of atherectomy in below-the-knee lesions. He reviews the most recent data from trials and registries such as XLPAD, LIBERTY 360, and many more.

Purpose: The incidence of lower limb amputation in patients with peripheral arterial disease (PAD) and chronic limb ischemia (CLI) has been shown to increase in recent years as a result of increasingly complex stenotic lesions and chronic total…

Drug-eluting bioresorbable scaffolds (BRS) have a bright future for below-the knee (BTK) management, , according to Brian DeRubertis, MD, from UCLA Division of Vascular Surgery.

Purpose: This case report describes use of the SAFARI technique for the treatment of chronic hand ischemia.

Purpose: Distal reentry can be a challenging endeavor, with an average failure rate of 40% reported when standard techniques are used.

Purpose: Pelvic congestion syndrome (PCS) is described as chronic pelvic pain arising from dilated and refluxing or insufficient pelvic veins. Reflux in the ovarian veins, with or without an obstructive venous outflow component, is reported to be…